Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

DEA Rule On Pseudoephedrine Limit “At Odds” With Meth Law - CHPA

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

A Drug Enforcement Administration "interpretive rule" on purchase amount limits for pseudoephedrine products conflicts with current methamphetamine control law, according to the Consumer Healthcare Products Association

You may also be interested in...



Pseudoephedrine Tablets Go Behind The Counter In Oklahoma

Legislation restricting the sale of pseudoephedrine tablets to licensed pharmacies was signed into law in Oklahoma on April 7 and is being considered by other states looking to adopt similar measures

Pseudoephedrine Tablets Go Behind The Counter In Oklahoma

Legislation restricting the sale of pseudoephedrine tablets to licensed pharmacies was signed into law in Oklahoma on April 7 and is being considered by other states looking to adopt similar measures

Pseudoephedrine Tablets Go Behind The Counter In Oklahoma

Legislation restricting the sale of pseudoephedrine tablets to licensed pharmacies was signed into law in Oklahoma on April 7 and is being considered by other states looking to adopt similar measures

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

See All
UsernamePublicRestriction

Register

PS096607

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By